Jim Simons
AURA icon

Jim Simons’s Aura Biosciences AURA Stock Holding History

Jim Simons’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$683K Sell
102,100
-43,100
-30% -$247K ﹤0.01% 2458
2025
Q4 		$791K Buy
145,200
+47,592
+49% +$283K ﹤0.01% 2382
2025
Q3 		$603K Sell
97,608
-33,940
-26% -$222K ﹤0.01% 2716
2025
Q2 		$823K Buy
131,548
+28,248
+27% +$165K ﹤0.01% 2601
2025
Q1 		$605K Buy
103,300
+19,600
+23% +$148K ﹤0.01% 2663
2024
Q4 		$688K Buy
83,700
+69,500
+489% +$654K ﹤0.01% 2689
2024
Q3 		$127K Sell
14,200
-57,900
-80% -$496K ﹤0.01% 3218
2024
Q2 		$545K Buy
72,100
+15,000
+26% +$110K ﹤0.01% 2658
2024
Q1 		$448K Buy
57,100
+28,600
+100% +$237K ﹤0.01% 2909
2023
Q4 		$253K Buy
28,500
+15,000
+111% +$127K ﹤0.01% 3049
2023
Q3 		$121K Sell
13,500
-6,000
-31% -$64.5K ﹤0.01% 3206
2023
Q2 		$241K Buy
19,500
+9,400
+93% +$100K ﹤0.01% 3223
2023
Q1 		$94K Sell
10,100
-3,000
-23% -$31.2K ﹤0.01% 3507
2022
Q4 		$138K Buy
+13,100
New +$167K ﹤0.01% 3532

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jim Simons's AURA Position: Q1 2026 in Review

Jim Simons reduced its Aura Biosciences (AURA) stake by 30% in Q1 2026, selling an estimated $247K and leaving 102,100 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Jim Simons first reported a position in AURA in Q4 2022 and has held it in 14 quarters since. The position peaked at $823K in Q2 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Jim Simons held 102,100 shares of Aura Biosciences worth $683K as of Q1 2026.
  • Jim Simons sold 43,100 Aura Biosciences shares in Q1 2026, an estimated $247K.
  • Aura Biosciences made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2458 holding.
  • Jim Simons first reported a position in Aura Biosciences in Q4 2022 and has held it in 14 quarters since.
  • Jim Simons's Aura Biosciences position peaked at $823K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.